ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
bar
|
1.0K |
414K |
14 |
13:24 |
13:24 |
ASX - By Stock
|
1.0K
|
414K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Daily Share Trades - any manipulation?
|
|
bar
|
17 |
4.3K |
1 |
11:10 |
11:10 |
ASX - By Stock
|
17
|
4.3K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Daily Share Trades - any manipulation?
|
|
bar
|
17 |
4.3K |
6 |
10:41 |
10:41 |
ASX - By Stock
|
17
|
4.3K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
On Track to Profitability, Price Target Increased (MST)
|
|
bar
|
147 |
23K |
4 |
10:19 |
10:19 |
ASX - By Stock
|
147
|
23K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Court Approval to Hold Scheme Meetings & Booklet Registered
|
|
bar
|
113 |
30K |
0 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
113
|
30K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
On Track to Profitability, Price Target Increased (MST)
|
|
bar
|
147 |
23K |
2 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
147
|
23K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
On Track to Profitability, Price Target Increased (MST)
|
|
bar
|
147 |
23K |
7 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
147
|
23K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
1 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
12K
|
6.2M
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Full Year Financial Results
|
|
bar
|
214 |
39K |
15 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
214
|
39K
|
15
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Full Year Financial Results
|
|
bar
|
214 |
39K |
7 |
31/08/24 |
31/08/24 |
ASX - By Stock
|
214
|
39K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Company Podcast
|
|
bar
|
19 |
3.8K |
6 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
19
|
3.8K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Full Year Financial Results
|
|
bar
|
214 |
39K |
0 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
214
|
39K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Significant Growth in Commercial Treatment Sales in Q4 FY24
|
|
bar
|
27 |
9.2K |
3 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
27
|
9.2K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Full Year Financial Results
|
|
bar
|
214 |
39K |
7 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
214
|
39K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Full Year Financial Results
|
|
bar
|
214 |
39K |
2 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
214
|
39K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
bar
|
375 |
66K |
4 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
375
|
66K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Appendix 4E and FY24 Financial Statements
|
|
bar
|
41 |
14K |
33 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
41
|
14K
|
33
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
bar
|
263 |
43K |
1 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
263
|
43K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
The Bear Room
|
|
bar
|
263 |
43K |
6 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
263
|
43K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
bar
|
375 |
66K |
1 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
375
|
66K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
bar
|
1.0K |
414K |
23 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
1.0K
|
414K
|
23
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
bar
|
375 |
66K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
375
|
66K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
EYE Summary (August 2024): Incredibly Undervalued
|
|
bar
|
375 |
66K |
4 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
375
|
66K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
3 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
bar
|
19K |
11M |
19 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
19K
|
11M
|
19
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
7 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
507
|
111K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
10 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
10
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
bar
|
3.2K |
1.4M |
18 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
18
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bar
|
11 |
3.1K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
11
|
3.1K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
507
|
111K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
17 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
507
|
111K
|
17
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
bar
|
1.0K |
414K |
6 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
1.0K
|
414K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
507
|
111K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Edwards buys JenaValve
|
|
bar
|
8 |
3.0K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
8
|
3.0K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
bar
|
1.0K |
414K |
19 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
1.0K
|
414K
|
19
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
3 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
13 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
13
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
29 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
29
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
7 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
7
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
0 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
507
|
111K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
0 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
507
|
111K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
CMS Proposes Major Increase in Reimbursement for Canaloplasty
|
|
bar
|
507 |
111K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
507
|
111K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Presentation FY24 Sales
|
|
bar
|
38 |
10K |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
38
|
10K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
0 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
bar
|
12K |
6.2M |
3 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Record Sales Results
|
|
bar
|
131 |
29K |
3 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
131
|
29K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Record Sales Results
|
|
bar
|
131 |
29K |
3 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
131
|
29K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
POTENTIAL RE-RATE CATALYST EVENT: RESULTS
|
|
bar
|
124 |
34K |
9 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
124
|
34K
|
9
|
|